statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peeling Back The Layers: Exploring Xencor Through Analyst Insights

Latest Ratings for XNCR
 DateFirmActionFromTo Feb 2022HC Wainwright & Co.MaintainsBuy Feb 2022BMO CapitalInitiates Coverage OnOutperform Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy
 View...

Xencor Regains CD20 x CD3 Bispecific T-Cell Engager

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, announced it will regain exclusive...

Decoding 6 Analyst Evaluations For Xencor

Xencor Reports First Quarter 2024 Financial Results

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for...

Analyst Scoreboard: 6 Ratings For Xencor

Xencor Appoints Bart Cornelissen as Chief Financial Officer

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart...

XNCR Crosses Below Key Moving Average Level

In trading on Friday, shares of Xencor, Inc (XNCR) crossed below their 200 day moving average of 21.32, changing hands as low as 20.93 per share. Xencor, Inc shares are currently trading...

Xencor (XNCR, $21.96) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that XNCR's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Xencor (XNCR, $22.43) price moved above its 50-day Moving Average on March 27, 2024

This price move could indicate a change in the trend, and may be a buy signal for investors...

Xencor (XNCR, $21.53) Stochastic Oscillator left the oversold zone on March 26, 2024

This is a signal that XNCR's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Volume	426,148.00
52-Wk High	$26.84
52-Wk Low	$16.49

XNCR Xencor Inc

About

Feed

News

Sentiment

Earnings

Fundamentals